| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |